TABLE 1

Summary statistics for aspirin pharmacokinetic parameters by treatment time point and acetaminophen (internal control)

Values are represented as median (interquartile range).

Period 1 (Morphine, 5 mg i.v. Bolus Injection)Period 2 (Placebo)
ASANCmax (mg/liter)tmax (min)AUC0–∞ (mg•h/liter)Cmax (mg/liter)tmax (min)AUC0–∞ (mg•h/liter)
Prior aspirin (−30, −15 min)101.5 (1.1–2.0)30 (28–45)90 (70–103)1.8 (1.4–1.9)30 (20–30)84 (60–103)
Simultaneous with aspirin (−5, 0, +5 min)151.6 (1.4–2.5)30 (20–30)100 (92–120)**1.6 (1.4–2.0)30 (20–30)79 (67–98)
Post aspirin (+15, +30 min)101.8 (1.5–2.1)25 (20–30)90 (67–123)1.9 (1.4–2.3)20 (20–30)82 (72–92)
Pooled (−30, −15, −5, 0, +5, +15, +30 min)351.8 (1.4–2.1)30 (20–30)98 (73–118)***1.7 (1.4–1.9)30 (20–30)82 (67–94)
Salicylic acid
Prior aspirin (−30, −15 min)106.6 (5.3–8.4)90 (60–98)1682 (1214–2161)7.2 (5.9–8.6)90 (56–90)1863 (1388–1923)
Simultaneous with aspirin (−5, 0, +5 min)156.7 (6.1–9.0)60 (60–90)1793 (1429–2478)7.6 (6.7–8.4)60 (60–60)1590 (1378–1958)
Post aspirin (+15, +30 min)107.0 (6.6–9.0)60 (45–90)1557 (1373–2451)7.1 (6.6–9.1)60 (60–90)1455 (1397–2553)
Pooled (−30, −15, −5, 0, +5, +15, +30 min)356.7 (6.1–8.3)60 (60–90)1700 (1408–2142)*7.3 (6.5–8.4)60 (60–90)1532 (1395–1923)
Acetaminophen
Prior aspirin (−30, −15 min)413 (8–17)90 (90–90)253 (1790–4252)15 (11–18)45 (19–83)2395 (1379–4020)
Simultaneous with aspirin (−5, 0, +5 min)613 (6–14)*105 (83–150)*2957 (2713–3835)17 (14–21)45 (30–60)3260 (2785–3482)
Post aspirin (+15, +30 min)453 (23–285)60 (45–90)3461 (2853–4353)53 (34–83)60 (60–90)2832 (1831–3975)
Pooled (−30, −15, −5, 0, +5, +15, +30 min)3513 (9–16)***90 (60–120)**3183 (1988–3482)18 (14–20)45 (30–60)3158 (2708–3961)
  • AUC, area under the concentration–time curve; Cmax, maximum plasma concentration; tmax, time to maximum plasma concentration.

  • * P < 0.05; **P < 0.01; ***P < 0.001 vs. placebo.